Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 46.00 | 76.50 | 0.6013 | 0.3998 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 65.00 | 76.50 | 0.8497 | 0.7840 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 52.00 | 76.50 | 0.6797 | 0.5255 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 66.00 | 76.50 | 0.8628 | 0.8032 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 5 | 156.25 | 28.48 | 69.00 | 76.50 | 0.9020 | 0.8604 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 5 | 156.25 | 28.48 | 96.00 | 76.50 | 1.2549 | 1.3453 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 5 | 156.25 | 28.48 | 70.00 | 76.50 | 0.9150 | 0.8792 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 5 | 156.25 | 28.48 | 116.00 | 76.50 | 1.5163 | 1.6783 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 5 | 156.25 | 28.48 | 82.00 | 76.50 | 1.0719 | 1.0998 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 5 | 156.25 | 28.48 | 118.00 | 76.50 | 1.5425 | 1.7106 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 5 | 156.25 | 28.48 | 85.00 | 76.50 | 1.1111 | 1.1534 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 5 | 156.25 | 28.48 | 127.00 | 76.50 | 1.6601 | 1.8540 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 5 | 156.25 | 28.48 | 91.00 | 76.50 | 1.1895 | 1.2590 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 5 | 156.25 | 28.48 | 119.00 | 76.50 | 1.5556 | 1.7267 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 79.00 | 76.50 | 1.0327 | 1.0456 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 5 | 156.25 | 28.48 | 113.00 | 76.50 | 1.4771 | 1.6295 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 81.00 | 76.50 | 1.0588 | 1.0818 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 5 | 156.25 | 28.48 | 55.00 | 76.50 | 0.7190 | 0.5868 |
| SK-BR-3 | Etoposide | 0.01 | uM | 5 | 156.25 | 28.48 | 86.00 | 76.50 | 1.1242 | 1.1712 |
| SK-BR-3 | Etoposide | 1 | uM | 5 | 156.25 | 28.48 | 80.00 | 76.50 | 1.0458 | 1.0638 |
| SK-BR-3 | PLX-4720 | 10 | uM | 5 | 156.25 | 28.48 | 89.00 | 76.50 | 1.1634 | 1.2240 |
| SK-BR-3 | Etoposide | 10 | uM | 5 | 156.25 | 28.48 | 84.00 | 76.50 | 1.0980 | 1.1356 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 5 | 156.25 | 28.48 | 96.00 | 76.50 | 1.2549 | 1.3453 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 5 | 156.25 | 28.48 | 104.00 | 76.50 | 1.3595 | 1.4808 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 93.00 | 76.50 | 1.2157 | 1.2937 |